Patent · US Active

Benzenesulfonyl-asymmetric ureas and medical uses thereof

US10501479B2 · kind B2 · utility

0Cited by

6References

51Claims

0Family size

Assignee

Helsinn Healthcare SA · CH

Inventors

Claudio Giuliano · Como, IT
Antoine Daina · Lausanne, CH
Claudio Pietra · Como, IT

Key dates

Filing date	Mar 21, 2017
Grant date	Dec 10, 2019
Priority date	—
Expiry date	Mar 21, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/02
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Benzenesulfonyl-asymmetric ureas are provided for the treatment of conditions modulated by the ghrelin receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.